Live Breaking News & Updates on Ierce pharma homepage

Stay informed with the latest breaking news from Ierce pharma homepage on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ierce pharma homepage and stay connected to the pulse of your community

AACR: Novartis aims to keep canakinumab's early lung cancer hopes alive despite metastatic failure

When Novartis failed in an attempt to repurpose Ilaris for metastatic non-small cell lung cancer (NSCLC), the Swiss pharma played up signs that it said supported continued exploration of the med in

Aacr-2022 , Ovartis , Anakinumab , On-small-cell-lung-cancer , Merican-association-for-cancer-research , Linical-trial-data , Laris , Ung-cancer , Clinical-data , Ierce-pharma-homepage , Pharma

Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court

The first of the three pharma juggernauts

Bristol-myers-squibb , Ilead-sciences , Ohnson-amp-johnson , Anssen , Awsuit , Ntitrust , Iv , Ettlement , Pharma , Ierce-pharma-homepage ,

Salvat heads to regulators with phase 3 data on ocular steroid

Salvat is gearing up to launch an ocular corticosteroid treatment for inflammation and pain in cataract surgery patients after finishing phase 3 trials and starting the approval process in the U.S.

Laboratorios-salvat , Teroids , Ataracts , Ataract-surgery , Cular-drug-delivery , Ionanotechnology , Drug-delivery , Linical-data , Ierce-pharma-homepage , Pharma ,

Salix: Half of IBS, chronic constipation patients lately find their condition 'more challenging to manage'

Patients with common but deeply uncomfortable gastrointestinal issues are still struggling to manage their conditions.

Salix-pharmaceuticals , Ausch-amp-lomb , Rritable-bowel-syndrome-with-constipation-ibsc- , Da , Pharma , Ierce-pharma-homepage , Marketing ,

Quviviq maker Idorsia touts Alliance for Sleep insomnia survey

Amid the launch of Idorsia's new insomnia drug Quviviq, the company and its Alliance for Sleep are raising awareness about chronic sleep issues.

Idorsia , Ohnson-amp-johnson , Erck-amp-co- , Nsomnia , Pharma , Ierce-pharma-homepage , Marketing ,

J&J aims to 'save legs, change lives' with new peripheral artery disease awareness effort

Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S.

Johnson-amp , Anssen , Anssen-pharmaceuticals , Ad , Eripheral-artery-disease , Arelto , Merican-college-of-cardiology , Merican-heart-association , Wareness-campaigns , Pharma , Ierce-pharma-homepage

Ten23 health expands former swissfillon facility in Visp, Switzerland

Ten23 health, a CDMO that launched just six months ago, continues to expan

Cdmo , Lant-expansion , Uto-injector , Witzerland , Facilites , Ierce-pharma-homepage , Manufacturing ,

Biogen's troubled Aduhelm hit with CMS slapdown—now what?

The Centers for Medicare & Medicaid Services (CMS) has

Biogen , Duhelm-aducanumab- , Ichel-vounatsos , Rug-reimbursement , Lzheimer-039s-disease , Enters-for-medicare-amp-medicaid-services-cms- , Nalysts , Marketing , Ierce-pharma-homepage , Pharma ,

Fierce Pharma Asia—Legend CSO's departure; Takeda's gene therapy deal; Pfizer's India revamp

Legend Biotech's founding chief scientific officer has left the company without a new destination. Takeda has signed another gene therapy deal with Evozyne to work on protein sequences.

Fierce-pharma-asia , Ell-amp-gene-therapy , Egend-biotech , Akeda , Fizer , Igital-marketing , Strazeneca , Arbour-biomed , Sv , Dmo , Asia

Merck, during a transition year, doled out nearly $30M to its pair of CEOs

With Merck taking the reins from retiring CEO Ken Frazier and handing them to Robert Davis at the exact midway point of 2021, how would the New Jersey-based drugmaker divvy up their pay for the yea

Merck , Obert-davis , En-frazier , Eo-pay , Rank-clyburn , Eytruda , Executives , Ierce-pharma-homepage , Pharma ,

Live Breaking News & Updates on Ierce pharma homepage

The first of the three pharma juggernautsBristol-myers-squibb , Ilead-sciences , Ohnson-amp-johnson , Anssen , Awsuit , Ntitrust , Iv , Ettlement , Pharma , Ierce-pharma-homepage ,

Patients with common but deeply uncomfortable gastrointestinal issues are still struggling to manage their conditions.Salix-pharmaceuticals , Ausch-amp-lomb , Rritable-bowel-syndrome-with-constipation-ibsc- , Da , Pharma , Ierce-pharma-homepage , Marketing ,

Amid the launch of Idorsia's new insomnia drug Quviviq, the company and its Alliance for Sleep are raising awareness about chronic sleep issues.Idorsia , Ohnson-amp-johnson , Erck-amp-co- , Nsomnia , Pharma , Ierce-pharma-homepage , Marketing ,

Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S.Johnson-amp , Anssen , Anssen-pharmaceuticals , Ad , Eripheral-artery-disease , Arelto , Merican-college-of-cardiology , Merican-heart-association , Wareness-campaigns , Pharma , Ierce-pharma-homepage

Ten23 health, a CDMO that launched just six months ago, continues to expanCdmo , Lant-expansion , Uto-injector , Witzerland , Facilites , Ierce-pharma-homepage , Manufacturing ,

The Centers for Medicare & Medicaid Services (CMS) hasBiogen , Duhelm-aducanumab- , Ichel-vounatsos , Rug-reimbursement , Lzheimer-039s-disease , Enters-for-medicare-amp-medicaid-services-cms- , Nalysts , Marketing , Ierce-pharma-homepage , Pharma ,